A Gene Network Regulating Lysosomal Biogenesis and Function

Telethon Institute of Genetics and Medicine, Via P. Castellino 111, 80131 Naples, Italy.
Science (Impact Factor: 33.61). 07/2009; 325(5939):473-7. DOI: 10.1126/science.1174447
Source: PubMed


Lysosomes are organelles central to degradation and recycling processes in animal cells. Whether lysosomal activity is coordinated
to respond to cellular needs remains unclear. We found that most lysosomal genes exhibit coordinated transcriptional behavior
and are regulated by the transcription factor EB (TFEB). Under aberrant lysosomal storage conditions, TFEB translocated from
the cytoplasm to the nucleus, resulting in the activation of its target genes. TFEB overexpression in cultured cells induced
lysosomal biogenesis and increased the degradation of complex molecules, such as glycosaminoglycans and the pathogenic protein
that causes Huntington’s disease. Thus, a genetic program controls lysosomal biogenesis and function, providing a potential
therapeutic target to enhance cellular clearing in lysosomal storage disorders and neurodegenerative diseases.

Download full-text


Available from: Michela Palmieri
  • Source
    • "Initial studies demonstrated that GLMP could enhance the expression from a peroxisome proliferator-activated receptor alpha (PPARα) responsive promoter in a ligand-dependent manner (Steffensen et al. 2007). Later studies have identified GLMP as an integral lysosomal membrane protein (Schieweck et al. 2009; Sardiello et al. 2009; Schröder et al. 2010). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Glycosylated lysosomal membrane protein (GLMP) has been reported to enhance the expression from a peroxisome proliferator-activated receptor alpha (PPARα) responsive promoter, but also to be an integral lysosomal membrane protein. Using myotubes established from wild type and Glmp(gt/gt) mice, the importance of GLMP in skeletal muscle was examined. Glmp(gt/gt) myotubes expressed a more glycolytic phenotype than wild type myotubes. Myotubes from Glmp(gt/gt) mice metabolized glucose faster and had a larger pool of intracellular glycogen, while oleic acid uptake, storage and oxidation were significantly reduced. Gene expression analyses indicated lower expression of three PPAR-isoforms, a co-regulator of PPAR (PGC1α), and several genes important for lipid metabolism in Glmp(gt/gt) myotubes. However, ablation of GLMP did not seem to substantially impair the response to PPAR agonists. In conclusion, myotubes established from Glmp(gt/gt) mice were more glycolytic than myotubes from wild type animals, in spite of no differences in muscle fiber types in vivo.
    Full-text · Article · Dec 2015 · Archives of Physiology and Biochemistry
  • Source
    • "This mechanism is suggested by the upregulation of the lysosomal glycoproteins LAMP1 and LAMP2 in cells treated with some cationic drugs, imatinib or chloroquine (Ertmer et al., 2007; Chen, Gombart & Chen, 2011). Ultimately, the process may be controlled by the lysosomal genesis transcription factor TFEB that is subjected to nuclear translocation upon activation (Sardiello et al., 2009) and such a protracted response to basic drugs has been recently reported in cultured cells (chloroquine: Roczniak-Fergusson et al., 2012; propranolol: Logan, Kong & Krise, 2014). (4) Intriguing tissue or cell type specificities were described for the formation of cationic drug reservoirs. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The proton pump vacuolar (V)-ATPase is the driving force that mediates the concentration of cationic drugs (weak bases) in the late endosome-lysosome continuum; secondary cell reactions include the protracted transformation of enlarged vacuoles into autophagosomes. We used the inherently fluorescent tertiary amine quinacrine in murine models to further assess the accumulation and signaling associated with cation trapping. Primary fibroblasts concentrate quinacrine ∼5,000-fold from their culture medium (K M 9.8 µM; transport studies). The drug is present in perinuclear granules that are mostly positive for Rab7 and LAMP1 (microscopy). Both drug uptake and retention are extensively inhibited by treatments with the V-ATPase inhibitor bafilomycin A1. The H + ionophore monensin also prevented quinacrine concentration by fibroblasts. However, inhibition of plasma membrane transporters or of the autophagic process with spautin-1 did not alter quinacrine transport parameters. Ancillary experiments did not support that low micromolar concentrations of quinacrine are substrates for organic cation transporters-1 to-3 or P-glycoprotein. The secondary autophagy induced by quinacrine in cells may derive from the accumulation of incompetent autophagolysosomes, as judged from the accumulation of p62/SQSTM1 and LC3 II (immunoblots). Accordingly, protracted lysosomogenesis is evidenced by increased expression of LAMP1 and LAMP2 in quinacrine-treated fibroblasts (48 h, immunoblots), a response that follows the nuclear translocation of the lysosomal genesis transcription factor TFEB and upreg-ulation of LAMP1 and −2 mRNAs (24 h). Quinacrine administration to live mice evidenced variable distribution to various organs and heterogeneous accumulation within the lung (stereo-microscopy, extraction). Dose-dependent in vivo autophagic and lysosomal accumulation was observed in the lung (immunoblots). No evidence has been found for transport or extrusion mechanisms modulating the cellular uptake of micromolar quinacrine at the plasma membrane level. As shown in vitro and in vivo, V-ATPase-mediated cation sequestration is associated, above a certain threshold, to autophagic flux inhibition and feedback lysosomogenesis. How to cite this article Parks et al. (2015), Autophagic flux inhibition and lysosomogenesis ensuing cellular capture and retention of the cationic drug quinacrine in murine models. PeerJ 3:e1314
    Full-text · Article · Oct 2015 · PeerJ
  • Source
    • "Our findings demonstrate that mitochondrial dysfunction results in autophagosome-lysosome fusion defects and reduced mitochondrial clearance by mitophagy, which are commonly observed in almost all sphingolipidoses (Lieberman et al., 2012). A predominant nuclear localization of TFEB has been detected in cells from mouse models of LSD (Sardiello et al., 2009). Mitochondrial respiration deficiency increases TFEB activation, suggesting that the TFEB pathway is activated as a cellular response to lysosomal stress after intralysosomal storage of nondegraded molecules. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The endolysosomal system is critical for the maintenance of cellular homeostasis. However, how endolysosomal compartment is regulated by mitochondrial function is largely unknown. We have generated a mouse model with defective mitochondrial function in CD4(+) T lymphocytes by genetic deletion of the mitochondrial transcription factor A (Tfam). Mitochondrial respiration deficiency impairs lysosome function, promotes p62 and sphingomyelin accumulation, and disrupts endolysosomal trafficking pathways and autophagy, thus linking a primary mitochondrial dysfunction to a lysosomal storage disorder. The impaired lysosome function in Tfam-deficient cells subverts T cell differentiation toward proinflammatory subsets and exacerbates the in vivo inflammatory response. Restoration of NAD(+) levels improves lysosome function and corrects the inflammatory defects in Tfam-deficient T cells. Our results uncover a mechanism by which mitochondria regulate lysosome function to preserve T cell differentiation and effector functions, and identify strategies for intervention in mitochondrial-related diseases. Copyright © 2015 Elsevier Inc. All rights reserved.
    Full-text · Article · Aug 2015 · Cell metabolism
Show more